Symptomtext
administered expired Fluzone Quad vaccination with no reported adverse event; Initial information regarding this unsolicited valid non-serious case from via Agency (Reference number- 00816412) was received from a via other health professional via consumer/non-hcp and transmitted to Sanofi on 18-Oct-2021. This case involved a 70 years old male patient reported about administered expired fluzone quad vaccination with no reported adverse event (expired product administered) while receiving vaccine Influenza Quadrival A-B Intradermal Vaccine [Fluzone]. The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. On 15-Oct-2021, the patient received a dose dose of suspect Influenza Quadrival A-B Intradermal Vaccine lot UJ567AB via intramuscular indication prophylactic vaccination(with unknon formulation, strength, dosage). On 15-OCT-2021 the patient developed a non-serious event administered expired fluzone quad vaccination with no reported adverse event (expired product administered) following the administration of Influenza Quadrival A-B Intradermal Vaccine. Action taken with Quadrivalent Influenza Vaccine (Fluzone) was not applicable. It was not reported if the patient received a corrective treatment for the event (administered expired Fluzone Quad vaccination with no reported adverse event). At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. No further information was reported.